In addition, aPD-1-PLTM-HMSNs@Sora inhibited VEGF-A (promoting tumor growth and angiogenesis) expression more efficiently than other treatments which was proved by immunohistochemical data (Fig. 4F, G). Here, VEGFA is linked to neoplasm.